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Abstract
The ileal Peyer's patch (PP) plays a central role in B cell development in young sheep and it is
hypothesized that this B cell development occurs independent of extrinsic antigen and T cells.
Therefore, it was of interest to examine ileal PP follicular (iPf) B cell responses to CD40 ligand, a
molecule integral to T cell-dependent B cell development. A variable level of CD40 expression was
detected on a subpopulation of iPfB cells and J558L cells, expressing a membrane form of mouse
CD40 ligand (mCD40L), interacted specifically with the CD40 molecule on iPfB cells. In response to
mCD40L the non-S phase iPfB cells were rescued from apoptotic cell death and there was a
marked proliferative response but viable cell number remained relatively constant. The mCD40L
also induced decreased cytoplasmic cAMP levels, blocked anti-lg-induced iPfB cell death and
induced functional IL-2 receptor expression on a subpopulation of iPfB cells. Many of the mCD40L-
induced responses of iPfB cells were similar to those reported for germinal centre and immature B
cells, and indicated that a cognate T cell-B cell interaction could influence iPfB cell proliferation
and differentiation. Finally, that mCD40L induced iPfB cell activation and differentiation was evident
as increased expression of CD5, the BAQ44A molecule, the CACT65A molecule and the expansion
of surface lgG1 + B cells. These mCD40L-induced phenotypic changes were also observed on
subpopulations of freshly isolated iPfB cells and jejunal PP follicular B cells. However, few iPfB
cells had a phenotype similar to that observed in co-culture with mCD40L and this suggested that
T cell-dependent B cell development may play a minor role in ileal PP B cell development. The
possible significance of CD40 signalling is discussed in terms of the selection of iPfB cells during
development.
Introduction
The interaction of the CD40 molecule, expressed on B cells
(1), and the CD40 ligand (CD40L), expressed primarily on
activated CD4 T cells (2), plays a central role in regulating T
cell-dependent B cell growth and differentiation. This has
been clearly demonstrated with in vitro systems where CD40
signalling induced B cell proliferation, cytokine respons-
iveness, isotype switching, and differentiation into plasma-
blasts and plasma cells (reviewed in 3). Furthermore, in vivo
studies have shown that blocking the interaction of CD40 with
CD40L inhibits primary and secondary immune responses to
T cell-dependent antigens (4), and identification of a defective
CD40L molecule in humans with X-linked hyper-IgM syndrome
confirmed that signalling was essential for germinal centre
formation and isotype switching (5). CD40 signalling may play
a role in both extrafollicular and germinal centre B cell
development. In particular, CD40 may provide an essential
co-signal with surface (s)lg for the rescue of centrocytes from
cell death (6-8). Associated with this rescue from cell death
is a reduction in cytoplasmic cAMP levels (9) and induction
of the Bcl-2 protein (10). Thus, CD40 signalling results in
numerous changes in B cell physiology that influence both B
cell growth and differentiation during a response to a T cell-
dependent antigen.
The ileal Peyer's Patch (PP) of sheep plays a central role
in B cell development. In young sheep, -70% of all B cells
are located within lymphoid follicles of the ileal PP (11) and
emigrant B cells make a major contribution to the B cell
populations in all lymphoid tissues (12,13). The ileal PP
follicular (iPf) B cells express membrane IgM and Ig light
chain (14) but are phenatypically and functionally immature
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(15-17). Furthermore, the ileal PP is a site of Ig repertoire
diversification by somatic hypermutation (18), but iPfB cell
development is distinct from the T cell-dependent and antigen-
dependent development of germinal centre B cells (4,5).
In contrast, iPfB cell proliferation appears to be antigen
independent (19), the lymphoid follicles involute in mature
animals (20), and there is a paucity of T cells in ileal PP
lymphoid follicles (15).
The paucity of T cells in the ileal PP, relative to jejunal PPs,
and the initiation of iPfB cell proliferation prior to birth have
been interpreted as evidence that iPfB cell development
occurs independently of antigen and T cells (20). However,
clustering of somatic mutations to the CDR regions of Ig X
light chain V genes (18), the marked increase in iPfB cell
emigration following birth (12) and the premature involution
of ileal PP follicles in sterile gut-loops (19) could equally be
interpreted as evidence that antigen, and perhaps T cells, do
play a role in both iPfB cell proliferation and the selection of
emigrant B cells. A T cell-dependent antigen selection of
emigrant iPfB cells would further imply that the TCR repertoire
'shaped' the Ig repertoire of circulating B cells. As one
approach to examining the possibility that T cell-dependent
antigens may be important for iPfB cell development we
studied their responses to CD40L, a molecule integral to T
cell-B cell interactions. We found that iPfB cells expressed
functional CD40 and that CD40 signalling influenced both
iPfB cell growth and differentiation. Finally, CD40L altered the
phenotype of cultured iPfB cells and we then analysed the
phenotype of freshly isolated iPfB cells for evidence of similar
phenotypic changes.
Methods
Reagents
Recombinant human (rh)IL-2 was purchased from British
Biotechnology (Oxford, UK); cholera toxin and propidium
iodide (PI) were purchased from Calbiochem-Behring (La
Jolla, CA); 3-isobutyl-1-methyl-xanthine (IBMX), phorbol myr-
istate acetate (PMA), calcium ionophore A23187, mitomycin
C and the PKH26 Red Fluorescent Cell Linker Kit were
purchased from Sigma (Buchs, Switzerland). F(ab')2 rabbit
anti-sheep IgM was purchased from Cappel Laboratories
(West Chester, PA). The 5-bromo-2'-deoxy-uridine (BrdU) and
mouse mAb specific for BrdU were purchased from
Boehringer-Mannheim (Mannheim, Germany). The isotype-
specific biotinylated and FITC- or phycoerythrin (PE)-conjug-
ated goat anti-mouse Ig antibodies were purchased from
Southern Biotechnology (Birmingham, AL). The following
mouse mAbs were used: Plg45A (sheep IgM), Blg312D3
(Sheep IgA), Blg715A (sheep lgG1), BAQ44A(B cell differenti-
ation molecule), CACT65A (B cell activation molecule) and
CACT116A (sheep IL-2 receptor; CD25); and were purchased
from VMRD (Pullman, WA); and ST1a (CD5) and 17D-13
(CD4) were produced at the Basel Institute for Immunology,
Basel, Switzerland. Iscove's modified Dulbecco's modified
Eagle's medium (IMDM) and fetal bovine serum (FBS) were
purchased from Gibco/BRL (Basel, Switzerland).
Cell isolation and culture
All experiments were conducted with tissues collected from
6-10 week old, Swiss White Alpine lambs or 144 day gestation
feti (Versuchsbetrieb Sennweid, Olsburg, Switzerland) of either
sex. Lymphoid follicles were released from ileum and jejunal
PPs by separating the mucosa from the muscularis externa
with a scalpel blade. The intact lymphoid follicles were
separated by washing gently with a swirling motion in a Petri
dish and then aspirating the medium. The washings were
repeated until extrafollicular cells were depleted and follicles
were then disrupted by repeated pipetting before filtering the
cells through a 20 urn nylon mesh (Small Parts, Miami Lakes,
FL). The washed jejunal PP follicles were incubated at 37°C
for 10 min in 0.02% EDTA (Flow, Irvine, UK) and then disrupted
by pipetting before filtering cells. These procedures produced
single cell suspensions with >97% viability. All procedures
were conducted with ice-cold PBS or IMDM and cells were
maintained on ice prior to culture. Blood mononuclear cells
(BMCs) were isolated by centrifugation over a 60% Percoll
solution (Pharmacia, Uppsala, Sweden). Cells were cultured
in serum-replaced IMDM, supplemented as previously
described (21), and 2% FBS was added. Cultures for viable
cell number, flow cytometry and cAMP assays were performed
in 6-well culture dishes (Nunc, Roskilde, Denmark) with
10 x 106 iPfB cells/well cultured in a final volume of 5
ml medium. During long-term co-culture, iPfB cells were
transferred every 2-4 days to fresh medium and re-stimulated
with CD40L/J558 cells, with or without rhlL-2 (10 ng/ml).
Proliferation assays were performed in 96-well plates with
2 x 105 iPfB cells/well and 1 (xCi [3H]thymidine (Amersham,
Buckinghamshire, UK) added 4 h prior to harvesting cells. The
[3H]thymidine incorporation was determined using standard
methods with a Betaplate 96-well Harvester and Betamax
liquid scintillation counter (LKB Wallac, Turku, Finland). Data
presented are the mean ± SD of values from five replicate
cultures. Viable cell number was determined from counts of
total cell number (Coulter Counter ZM; Coulter Electronic,
Hialeah, FL) multiplied by the percent cells in R1 (see Fig.
4b). Differences in viable cell number and BrdU incorporation
were compared using a two-way, one-tailed Student's t-
test (22).
Soluble hCD40-Hn, soluble mCD40L-CD8cc and mCD40LJ
J558L cells
The production of soluble recombinant fusion proteins of
human CD40 with human Ign [hCD40-Hn; (2)] and murine
(m)CD40L-CD8a (23) was as described. mCD40L was cloned
into a plasmid construct to give membrane expression and
permit L-histidinol selection of transfected J558L cells (pro-
duced by P. Lane, Basel Institute for Immunology, Basel,
Switzerland). A transfected J558L clone, expressing high
levels of CD40L, was selected (CD40L/J558). The CD40L/
J558 cells were prepared for co-culture by incubating with
50 ng/ml mitomycin C for 1 h at 37°C and y-irradiating with
6000 rad. This treatment did not reduce membrane expression
of mCD40L, as detected by hCD40-Hn binding, but inhibited
all CD40L/J558 proliferation ([3H]thymidine incorporation) and
cells remained intact for 4-5 days.
PKH labelling
The manufacturer's protocol (Sigma) was followed for PKH26
labelling of cell suspensions with a 3 min incubation. Viability
of labelled cells was confirmed by flow cytometric analysis of
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FSC and co-culture of labelled and unlabelled iPfB cells
confirmed there was no difference in cell survival. However,
during a 48 h co-culture there was low level PKH26 transfer
to unlabelled cells that was apparent as a shift in mean
fluorescence intensity (FL3) from 4.55 (control) to 6.88 (control
cells co-cultured with PKH26-labelled cells).
Flow cytometry
Phenotypic analyses of cultured cells were restricted to viable
cells (Pl~ FALShi) and mAb binding for single and dual-
labelling was detected with FITC- and PE-conjugated isotype
specific goat anti-mouse Ig antibodies. The mCD4OL-CD8oc
protein was detected with PE-conjugated rat monoclonal anti-
mouse CD8oc (Caltag, San Francisco, CA) and hCD40-Hu. was
detected with PE-conjugated goat anti-human IgM (Southern
Biotechnology). Cytophilic Ig was removed prior to analyses
of slg on freshly isolated cells by incubating cells at 37°C for
30 min in PBS. This procedure was repeated after pelleting
cells and resuspending in fresh PBS. All analyses were
performed with a FACScan, using Lysis II program, and cell
sorting (R1; see Fig. 3b) was performed with a FACStar Plus
(Becton Dickinson, Mountain View, CA).
cAMP assay
iPfB cells were stimulated as described in Results and 2 x 106
viable cells were sorted (R1; see Fig. 3b) for duplicate assays.
cAMP was allowed to accumulate during a 1 h incubation
with IBMX (5 x 1CT4 M) before cells were pelleted, solubilized
in 500 u.l absolute ethanol and insoluble material separated
by centrifugation. The supernatant of each sample was desic-
cated in a rotary vacuum drier (Speed-Vac; Savant Instru-
ments, Farmingdale, NY) and then reconstituted in 100 |il of
cAMP buffer. cAMP was quantitated with a competitive binding
radioimmunoassay (NEN-Dupon, Regensdorf, Switzerland).
BrdU incorporation and detection
Lambs were injected intravenously with 20 mg BrdU/kg 30
min prior to tissue collection. Cytospots were prepared with
freshly isolated ileal or jejunal PP follicular cells or FACStar
sorted cultured iPfB cells (R1; see Fig. 4b). Incorporated
BrdU was detected as described previously (17) with the
modification that BrdU-specific mAb was detected with
biotinylated goat anti-mouse lgG1 and developed with the
Vectastain Elite ABC Kit (Vector, Burlingame, CA) using 3,3-
diaminobenzidine (Fluka, Buchs, Switzerland) as the sub-
strate.
Results
iPfB cells express a functional CD40 molecule
The binding of soluble mCD40L-CD8a fusion protein indi-
cated that a subpopulation (56.2 ± 6.4%; n = 6 lambs) of
iPfB cells expressed a detectable level of the CD40 molecule
(Fig. 1a). A variable level of CD40 expression was apparent
from the histogram width and an analysis of forward light
scatter (FSC; relative cell size) and mCD40L-CD8a labelling
intensity revealed an association between cell size and CD40
expression: high level CD40 expression was restricted to
large (FSChi) B cells while a subpopulation of small (FSC'°) B
cells did not express a detectable level of CD40 (Fig. 1a,
inset). This suggested that the avidity of the soluble mCD40L-
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Fig. 1. Expression of functional CD40 molecules on a subpopulation
of iPfB cells, (a) Flow cytometric analysis of soluble mCD40L-CD8a
binding by iPfB cells. A variable level of mCD40L-CD8a binding was
apparent from the range of fluorescence intensity (open histogram)
when compared with control (solid histogram). The dot scatter plot
(insert) revealed -60% iPfB cells bound a detectable level of
mCD40L-CD8a. The highest level of binding was on large cells
(FSChi) and many small cells were negative or labelled at a low level,
(b) Co-culture with mCD40L-transfected cells (CD40L/J558) induced
a dose-dependent proliferative response not observed with non-
transfected cells (J558) or CD40L/J558 cells pre-incubated with
soluble hCD40-Hn. (c) Proliferative responses induced by CD40L/
J558 cells were similar in amplitude and kinetics for B cells from a
variety of lymphoid tissues. Data presented are mean ± SD of values
from four replicate cultures.
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Fig. 2. A comparison of soluble mCD40L-CD8a binding by BMCs,
freshly isolated iPfB cells and cultured iPfB cells, (a) A distinct
subpopulation of BMCs bound soluble mCD40L-CD8a. (b) A low but
detectable level of mCD4OL-CD8oc binding was associated with most
FALShi iPfB cells and a subpopulation of FSC10 iPfB cells, (c) A high
level of mCD40L-CD8o binding was observed for all viable iPfB cells
(Pl~) cultured for 72 h in IMDM + 2% FBS. (d) A high level of
mCD40L-CD8a binding was observed for all iPfB cells following a
72 h co-culture with mCD401_/J558 cells. The percent cells binding
a detectable level of soluble mCD40L-CD8a is indicated in the upper
right corner and background fluorescence was determined using
cells reacted with PE-conjugated rat anti-mouse CD8a. The x-axis
presents the log mean fluorescence intensity of mCD40L-CD8a
binding as detected with PE-rat anti-mouse CD8a (CD40) and the
y-axis presents relative cell size as forward light scatter (FSC).
CD8a fusion protein may limit the detection of CD40
expressed on small iPfB cells. However, soluble mCD40L-
CD8a fusion protein clearly labelled a distinct population of
Control
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CD40L/U558
CD40UJ558 + Anti-lg
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Fig. 3. mCD40L inhibited iPfB cell death. Co-culture for 24 h with 5%
CD40L/J558 cells (CD40L/J558) rescued 50-60% of iPfB cells but
viable cell number then remained relatively constant during a 5 day
culture period. Addition of soluble rabbit anti-sheep IgM (anti-lg; 40
ng/ml) to cultures resulted in the death of all iPfB cells within 72 h.
This cell death exceeded that observed in the absence of anti-lg
(control). Addition of soluble anti-lg had no effect on viable iPfB cell
number during co-culture with CD40LAJ558 cells (CD40L/J558 +
anti-lg). Data presented are mean ± SD of values from three replicate
experiments.
blood mononuclear cells (BMC) (Fig. 2a) and the percent
slgM+ cells (40.1 ± 4.8%; n = 5) approximated the percent
cells labelled by soluble mCD40L-CD8a fusion protein (41.5
± 5.9%; n = 5). Dual-labelling for slgM and CD40 expression
indicated that all slgM+ BMC expressed CD40 but a small
subpopulation of slgM" cells also bound detectable levels of
soluble mCD40L-CD8a fusion protein (data not shown). In
contrast, -95% of all iPfB cells are slgM+ but only 60%
of these cells bound a detectable level of soluble mCD40L-
CD8a fusion protein (Fig. 2b). Furthermore, despite the rela-
tively larger size (greater FSC) of iPfB cells, when compared
with BMC, there was a relatively lower level of mCD40L-
CD8a fusion protein binding on the iPfB cells. Finally, all
viable iPfB cells (PI"), surviving 72 h in culture in either the
absence (Fig. 2c) or presence of CD40L/J558 cells (Fig. 2d),
bound a high level of soluble mCD40L-CD8a fusion protein.
Notable in these 72 h cultures was the absence of viable,
FALS10 iPfB cells which were observed in cell suspensions
prepared from ileal PP lymphoid follicles (Fig. 2b).
The specificity of the interaction between mCD40L-CD8a
and the sheep CD40 molecule was determined by co-culturing
iPfB cells with CD40L/J558 cells. A marked proliferative
response was observed when iPfB cells were co-cultured
CD40L/J558 cells (Fig. 1b). In contrast, neither non-trans-
fected J558L cells nor CD40L7J558 cells, pre-incubated for
60 min with soluble hCD40-Hn to block the CD40 molecule,
induced an increased iPfB cell proliferative response (Fig.
1b). The CD40LAJ558-induced proliferative responses were
also dose-dependent. Increased iPfB cell proliferative
responses were apparent in 48 h co-cultures with as few as
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Table 1. mCD40L rescues non-S-phase iPfB cells from cell death
Culture
Freshly isolated iPfBc
Control-24 he
CD40L-24 h1
BrdU+
42.7 ±
77.3 ±
49.3 ±
cells'3
3.5d
8.89
6.59
Viable
BrdU4
4.3 ±
2.5 ±
2.7 ±
cell no. (x 1C
0.4
0.3
0.3
,-6 )a
BrdU"
5.7 ±
0.7 ±
2.7 ±
0.4
0.1h
0.3h
Total
1O.0
3.2 ±
5.4 ±
0.3
0.4
Ratio
cells
0.75
3.57
1.00
of BrdU+/BrdU"
±0.1
±0.4*
± 0.21
aEach culture initiated with 10 x 106 viable iPfB cells. Percent viable cells determined by PI exclusion and FSC (Fig. 4b; R1).
bBrdU incorporation was detected by immunoperoxidase stain and determined from counts of 500 cells per cytospot of sorted viable cells
(Fig. 4b;R1).
cLamb injected with 20 mg BrdU/kg body weight 30 min prior to iPfB cell isolation.
dData presented are mean ± SD of values from seven experiments.
eiPfB cells cultured in IMDM/P + 2% FBS.
•iPfB cells co-cultured with 5% CD40L/J558 cells.
9"iSignificant differences ( P < 0.01) between control and CD40L cultures.
0.15% mCD40L/J558 cells and maximal proliferative
responses were observed with 2.5% mCD40L/J558 cells.
Finally, B cells from a variety of lymphoid tissues displayed a
proliferative response of similar amplitude and kinetics when
co-cultured with CD40L/J558 cells (Fig. 1c). Also apparent in
co-cultures of iPfB cells and mCD40L/J558 was a clustering
of B cells on the surface of mCD40LVJ558 cells and the
size of these cell clusters increased during co-culture (data
not shown).
mCD40L rescues non-S-phase iPfB cells from cell death
mCD40L not only induced a proliferative response (Fig. 1b)
but in 24 h co-cultures with mCD40L/J558 cells there was a
marked increase in viable iPfB cell number when compared
to 'control' cultures (Fig. 3). However, from day 2 to 8 of co-
culture viable iPfB cell number remained relatively constant.
This raised questions regarding which iPfB cells responded
to mCD40L and how proliferative responses increased despite
a constant viable cell number. To determine if CD40 signalling
altered the fate of both resting and proliferating iPfB cells the
S-phase iPfB cells were labelled with BrdU during a 30
min in vivo exposure. Approximately 40% iPfB cells had
incorporated BrdU and in 24 h 'control' cultures the S-phase
cells displayed a relatively greater survival than non-S-phase
cells (Table 1). Only 12% of non-S-phase cell were viable
after 24 h in culture while 58% of S-phase iPfB cells were
viable after the same period. However, co-culture with CD40L7
J558 cells increased 4-fold the survival of non-S-phase cells
(BrdU") but did not significantly change the survival of S-
phase cells (BrdU+) (Table 1). To further characterize the
mCD40L rescue of iPfB cells from cell death the iPfB cells
were labelled with the lipophilic fluorochrome PKH26 prior to
culture (Fig. 4a). This permitted an analysis of iPfB cell survival
and proliferation during a longer co-culture period with CD40L7
J558 cells. PKH26 inserts into cell membranes and with each
division distributes equally to progeny cells. A uniformly high
level of PKH26 labelling was achieved (Fig. 4a; histogram ii)
and mean PKH26 labelling intensity of viable iPfB cells
declined ~4-fold during a 4 day culture period (Fig. 4a;
histogram iii). This confirmed that most viable iPfB cells had
undergone approximately two cell divisions. However, the
FL3
Fig. 4. mCD40L rescued iPfB cells from cell death but did not alter
the rate of proliferation, (a) iPfB cells labelled with PKH26 (histogram
ii; MFI = 3571) displayed high intensity fluorescence when compared
with unlabelled cells (histogram i). Following 4 days in culture PKH26
labelling declined -4-fold for viable iPfB cells both in the presence
or absence of CD40L/J558 cells [histogram iii; MFI = 325 (control)
and 349 (CD40L/J558 cells)], (b) Viable iPfB cells (R1) were defined
as a population that excluded PI (FL3 low) and displayed FSC greater
than Pl+ cells, (c) In control cultures there was cell death with each
cell division which was apparent in the continuous contour plot for
PKH26 fluorescence (FL3) of the FALS'° cells located beneath the
population of FSChi viable cells (10,000 cells from R1). The contour
plot intensity for FALSto cells-also indicated cell death was greatest
prior to the first division (FL3 > 103). (d) Co-culture with CD40L/J558
cells eliminated much of the PKH26 contour plot for dead cells
(FALSto) except for a small population that never divided (FALS10; FL3
>103). Data are for 10,000 viable cells collected in R1.
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increased width of histogram iii, when compared to histogram
ii, indicated considerable variation in cell division within the
viable iPfB cell population. For these analyses viable iPfB
cells (Fig. 4b; R1) were identified as PI" (2.5 ng/ml PI; FL3'°)
and FSChi. Dead iPfB cells were identified as Pl+ (FL3hi)
and FSC'°. However, Pl~ cells (FL3'°) that were FSC'° were
excluded from R1 after Giemsa stained cytospots of FACStar
sorted cells revealed this population had nuclear condensa-
tion and fragmentation typical of apoptotic cells (data not
shown). Furthermore, during a continual lOminflowcytometric
analysis there was a progressive increase in the level of PI
incorporation in this population of FSC10 cells (data not shown).
Thus, subsequent analyses of iPfB cell survival in culture, with
or without CD40L/J558 cells, was determined by collecting
10,000 events in R1 (viable cells) and comparing this to the
total number of PKH26 labelled events collected (Fig. 4c and
d). When the contour plots were compared for control cultures
(Fig. 4c) and co-cultures with CD40L/J558 cells (Fig. 4d)
there was a noticeable reduction in the frequency of PKH26-
labelled (FL3) dead cells (FSC'°) following co-culture with
CD40L/J558 cells. Control cultures displayed extensive cell
death prior to the first cell division (FL3 >103) and cell death
with each cell division was evident in the continuous FL3
contour plot for FSC'° cells (Fig. 4c). In contrast, iPfB cell
death during co-culture with CD40L/J558 appeared to be
much lower and restricted primarily to cells that had not
divided (FL3 >103; Fig. 4d). This was consistent with data
from Table 1 that indicated 35% of non-S-phase iPfB cells
died during the first 24 h of co-culture with CD40L/J558 cells.
However, with no apparent cell death (Fig. 4d) and an average
doubling time of 48 h (Fig. 4a) the viable iPfB cell number
should have increased significantly after 4-5 days in co-
culture with mCD40L (Fig. 2). These observations indicate
that iPfB cell death continued in co-cultures with CD40L/J558
cells but iPfB cells may have died by necrosis which would
result in cell disintegration and no PKH26-labeled cell frag-
ments would be detected.
mCD40L inhibits anti-lg induced iPfB cell death
Antigen recognition by the Ig receptor should be part of T
cell-dependent B cell development (3) but slg on iPfB cells
transduces a signal that induces cell death (16). This was
apparent in cultures with soluble rabbit anti-sheep Ig where
few iPfB cells survived after 72 h and the decline in viable
cell number exceeded that of control cultures (Fig. 3). Thus,
we determined if mCD40L could alter iPfB cell death induced
by slgM signalling. The mCD40L completely inhibited anti-lg-
induced iPfB cell death [40 ng/ml F(ab')2 rabbit anti-sheep
IgM] with viable cell number similar for iPfB cells co-cultured
with CD40L/J558 cells in the presence or absence of anti-lg
(Fig. 3). It has also been observed that CD40L induced
decreased cAMP levels in human germinal centre B cells
and this second messenger pathway may play a role in
determining the survival of these cells (9). Therefore, it was
of interest to examine the effects of mCD40L on cAMP levels
in iPfB cells and to extend previous observations by examining
cAMP levels during CD40 and slgM co-signaling. Freshly
isolated iPfB cells had elevated cytoplasmic cAMP levels
(Fig. 5; control-0 h) relative to blood lymphocytes (1.5 ± 0.6
Culture Treatment
CD40L • Antl-Ig - 24 h
CD40L • Antl-Ig - 4 b
C D 4 0 L - 4 b
Antl-lg 3 4 b
Antl-lg - 4 b
C o n t r o l - 2 4 b
Control - 4 b
C o n t r o l - O b
0 10 20
Cytoplasmic cAMP- pmol/ml
Fig. 5. mCD40L reduced the level of cytoplasmic cAMP in iPfB cells
but co-signalling by slg induced elevated cAMP levels. Addition of
soluble anti-lg to cultured iPfB cells (Anti-lg-4 h; anti-lg-24 h) did not
significantly change cAMP levels. In contrast, co-culture with CD40L/
J558 cells markedly reduced iPfB cell cytoplasmic cAMP levels within
4 h (CD40L-4 h) and cAMP levels remained low after a 24 h co-
culture (CD40L-24 h). Addition of soluble anti-lg during iPfB cell co-
culture with CD40L/J558 cells did not alter cytoplasmic cAMP levels
after 4 h (CD40L + anti-lg-4 h) but cAMP levels increased after 24
h (CD40L + anti-lg-24h). Data presented are the mean ± SD of values
from three experiments and assays were performed in duplicate with
1X106 viable iPfB cells (R1; Fig. 2b).
pmol/ml) and maintained an elevated cAMP level during
culture (Fig. 5; control-4 h; control-24 h). The addition of
soluble anti-lg did not appear to alter cAMP levels in viable
iPfB cells (Fig. 5) but a 1 h incubation with cholera toxin
(1X10~9 M) increased the cytoplasmic cAMP level 5-fold
(153.8 ± 16.1 pmol/ml for 106 viable cells) and a 1 h incubation
with phorbol ester (PMA; 200 nM) plus calcium ionophore
A23187 (200 nM) induced a 3-fold decrease (5.7 ± 0.3 pmol/
ml for 106 viable cells). These changes in cytoplasmic cAMP
levels persisted for at least 24 h. The mCD40L also induced
a 4-fold decrease in cAMP levels within 4 h that persisted for
at least 24 h (Fig. 5). However, when iPfB cells were co-
cultured with CD40L/J558 cells and anti-sIgM (40 ng/ml) then,
after a 24 h incubation, there was a marked elevation of cAMP
levels (Fig. 5). Thus, iPfB cell survival during CD40 and slg
co-signalling was not dependent on a mCD40L-induced
inhibition of cAMP levels.
mCD40L induces IL-2 expression and iPfB cell differentiation
Antigen-dependent T cell-B cell interactions include the pro-
duction of a number of T cell cytokines and an increasing
number of cytokines have been shown to influence B cell
growth and differentiation in conjunction with CD40 signalling
(reviewed in 3). Thus, we investigated the possibility that
mCD40L altered iPfB cell cytokine responsiveness. Flow
cytometric analyses, following iPfB cell co-culture for 48 h
with CD40L/J558 cells, revealed a 10-fold increase in the
percent cells expressing detectable levels of IL-2R and
the percent cells expressing IL-2R increased further in the
presence of rhlL-2 (10 ng/ml; Table 2). Greater than 50% of
iPfB cells expressed detectable levels of IL-2R after 8-10
days of co-culture with CD40L/J558 cells and rhlL-2. That
the IL-2R was functional was evident in the rhlL-2-induced
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Table 2. iPfB cell phenotypic changes during co-culture with CD40L/J558 cells and rhlL-2
Phenotype
slgM
slgGI
slgA
BAQ44A
CACT65A
IL-2R
CD5+ slgM+c
CD5+ slgG1 +
PCsd
CD5hl
CD4+ T cells
Percent positive cellsa
Follicular B cellsb
96.5 ± 2.8
2.7 ± 1.3
0.3 d
6.6 d
3.5 d
0.8 d
2.5 d
14.8 d
0.8 d
t 0.3
t 5.8
: 2.1
i 0.5
t 1.8
t 5.9
t 0.6
0.50 ± 0.24
0.45 ± 0.20
Cultured ileal
Days 2-4
CD40L
94.4 ± 5.9
33.0 ± 4.4
0.2 ± 0.2
57.0 ± 5.9
92.0 ± 5.0
13.5 ± 3.0
78.6 ± 3.0
17.0 ± 3.0
17.5 ± 3.2
0.10 ± 0.05
0.09 ± 0.04
PP B cells
CD40L + rhlL-2
93.8 d
33.8 d
0.25 d
61.2 d
93.4 d
30.4 d
78.0 d
10.9 d
23.6 d
t 3.3
t 4.0
t 0.2
t 3.4
t 2.8
t 3.1
t 4.4
t 2.9
t 4.9
0.08 ± 0.04
0.08 ± 0.05
Days 8-10
CD40L
84.8 ± 6.7
30.7 ± 4.2
0.1 :
89.6 :
86.5 :
20.9 :
73.5 :
16.0 :
t0.1
t 6.0
t 7.8
t 4.2
t 5.9
t 3.4
N.D.
0.10 ± 0.06
0.11 ±0.05
CD40L + rhlL-2
89.0 ± 4.3
31.5 ± 3.9
0 .3 :
63.0 :
79.0 d
58.6 d
63.6 d
11.3 d
t 0.2
t 5.5
t 7.0
t 6.2
t 7.9
i 2.8
N.D.
0.08 ± 0.05
0.07 ± 0.04
aData presented are mean ± SD of values from six experiments.
bCell suspension prepared from isolated lymphoid follicles of the ileal PP.
cValues presented are the percent slgM+ or s lgGI+ cells that co-expressed CD5.
dPCs were quantitated from counts of 1000 cells in cytospots of sorted viable cells (Fig. 4b; R1). Isotype specific plasma cells (IgM, lgG1,
IgA) were detected by immunoperoxidase staining but >95% of plasma cells were consistently lgM+.
proliferative response induced by mCD40L (Fig. 6a) and the
increased iPfB cell viable number when rhlL-2 was added to
iPfB cell co-cultures with CD40L/J558 cells (Fig. 6b). A 6-6
day lag in the rhlL-2-induced increase in iPfB cell viable
number may be consistent with the expansion of a subpopul-
ation of IL-2R expressing cells (Table 2).
Phenotypic analyses revealed other changes that occurred
when iPfB cells and CD40L/J558 cells were co-cultured.
Within 48 h the CACT65A activation molecule (25) was
expressed on most iPfB cells but the percent iPfB cells with
detectable expression declined after 8-10 days (Table 2) and
was detected on <20% of cells following 16-18 days of co-
culture with CD40L/J558 cells and rhlL-2 (data not shown).
Also, within 48-96 h of co-culture the percent s lgGI+ B cells
increased 10-fold and this apparent isotype-switching was
not influenced by the addition of rhlL-2 (Table 2). To determine
if IgGi isotype switching or the expansion of an isotype
switched population of iPfB cells occurred we examined the
responses of naive iPfB cells isolated from three feti (day 144
of a 150 day gestation period) and co-cultured with CD40L/
J558 ± rhlL-2. The fetal iPfB cells and iPfB cells from lambs
displayed similar proliferative responses and changes in
viable cell number during co-culture with CD40L/J558 cells
± rhlL-2 (data not shown). However, after fetal iPfB cells were
co-cultured with CD40L/J558 cells and rhlL-2 for 7-10 days
there were only 3.8 ± 1.2% (n = 3) s lgGI+ cells and 0.1 ±
0.1% (n = 3) slgA+ cells. Thus, the interaction with CD40L
and IL-2 induced very little isotype switching in naive iPfB
cells and the large increase in s lgGI+ cells, observed for
lambs, probably results from the expansion of isotype-
switched B cells. Furthermore, few slgA+ iPfB cells were
observed during the co-culture of fetal or lamb iPfB cells with
CD40L/J558 cells ± rhlL-2 (Table 2). The mouse mAbs
specific for sheep IgA and lgG1 are the same isotype (IgGi).
Thus the absence of detectable IgA provided a control for
the specificity of lgG1 detection and also indicated that ileal
PP follicles were not a site for the generation of IgA committed
B cells. The large increase in plasma cells following 2-4 days
of culture indicated that CD40 signalling may induce B cell
differentiation but this was largely restricted to lgM+ plasma
cells. Finally, co-culture with CD40L/J558 cells consistently
induced low level CD5 expression on -80% of slgM+ and
10-20% of s lgGI+ iPfB cells and the BAQ44A differentiation
molecule was expressed on 50-60% of iPfB cells (Table 2).
In the absence of rhlL-2, the BAQ44A molecule was expressed
on most iPfB cells after 8-10 days in co-culture with CD40L7
558 cells. Less than 0.5% T cells (CD5hi; CD4+) were present
in iPfB cell suspensions and the number of T cells declined
to the limit of detection during the co-culture period (Table
2). Furthermore, 1-2% of the cells in iPfB cell suspensions
were macrophages and stromal cells but after three passages
during co-culture with CD40L/J558 cells the plastic-adherent
macrophages were no longer evident (data not shown).
Analysis of CD5, BAO44A and Ig isotype expression on ileal
and jejunal PP follicular B cells
The phenotypic analyses of iPfB cells co-cultured with CD40L7
J558 cells indicated that mCD40L altered the expression of
BAQ44A, CD5 and slgGI (Table 2). Therefore, it was of
interest to analyse the expression of these antigens on
lymphocytes freshly isolated from lymphoid follicles of the
ileal PP for possible evidence of T cell-dependent B cell
develoment. The phenotype of lymphocytes isolated from
lymphoid follicles of the jejunal PP was also analysed since
this gut-associated tissue appears to function as a typical
antigen-dependent secondary lymphoid tissue (20). That the
jejunal PP functions to generate many antigen-specific B cells
was evident in the high frequency of CD4+ T cells together
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Table 3. Analysis of CD5, BAQ44A and Ig expression by cells
isolated from lymphoid follicles of the ileal and jejunal PPs
2 3
Days In Culture
6 8 10 12
Days in culture
16 18
Fig. 6. mCD40L induced IL-2 responsiveness apparent as increased
iPfB cell proliferation and viable cell number following addition of
rhlL-2. (a) iPfB cell proliferation declined during culture (control) and
addition of rhlL-2 (rhlL-2) did not significantly change the proliferative
response. Co-culture with 5% CD40L/J558 cells (CD40L) significantly
increased the iPfB cell proliferative response and induced
responsiveness to rhlL-2 (10 ng/ml; CD40L/rhlL-2). The iPfB cell
responsiveness to rhlL-2 was maximal following a 72 h co-culture
with CD40L/J558 cells, (b) During long-term co-cultures with CD40LJ
J558 cells (CD40L) viable iPfB cell number remained relatively
constant for 7-10 days and then declined. In contrast, addition of 10
ng/ml rhlL-2 (CD40L/rhlL-2) resulted in a significantly increased viable
iPfB cell number between days 10 and 15 of co-culture. Data
presented are mean ± SD of values from three experiments. iPfB
cells were transferred to fresh co-cultures at each data point.
with l gG i + and lgA+ B cells (Table 3). On the basis of
BAQ44A, CD5 and slgG1 expression a similar estimate was
obtained that the jejunal PP had a 10-fold greater level of T
cell-dependent B cell development than did the ileal PP (Table
3). The paucity of lgA+ B cells and isotype-switched plasma
cells (PCs) in ileal PP follicles made it difficult to compare the
frequency of these population between the two PPs but the
frequency of lgM+ PCs, relative to slgM+ B cell number, was
similar for both ileal and jejunal PP follicles (Table 3). Finally,
the large SD for numbers of PCs and lgG1 isotype-switched
Phenotype
slgM
slgG1
slgA
BAQ44A
CD5+ slgM+b
CD5+s lgG1+ c
lgM+ PCsb
lgG+ PCs
lgA+ PCs
CD4+ T cells
Percent positive
Ileal PP
follicular cells
96.5 ± 2.8
2.7 ± 1.3
0.3 ± 0.3
6.6 ± 5.8
2.5 ± 1.8
14.8 ± 5.9
0.8 ± 0.6
0.1 ± 0.3
<0.01
0.45 ± 0.20
cells3
Jejunal PP
follicular cells
39.6 ± 7.4
26.5 ± 8.4
16.3 ± 7.8
79.0 ± 6.9
28.9 ± 8.6
56.0 ± 7.0
0.4 ± 0.3
2.8 ± 0.6
2.1 ± 0.5
13.8 ± 5.3
Comparative
frequency
jejunal PP/
ileal PP
0.4
9.8
54.3
12.0
11.6
3.8
0.5
28.0
NDd
30.6
aData presented are mean ± SD of values from the analyses of
cell suspensions prepared from isolated lymphoid follicles of the
jejunal and ileal PPs of six lambs (6-10 weeks old).
bPCs were quantitated from counts of 1000 cells in cytospots and
isotype specific plasma cells (IgM, lgG1, IgA) were detected by
immunoperoxidase staining.
cValues presented are the percent slgM+ or slgG1+ cells that co-
expressed CD5.
dND, not determined.
B cells in the ileal PP follicles reflected the broad variation
among lambs, as might be expected if variable antigenic
experiences altered iPfB cell differentiation.
Discussion
The present investigation determined that a subpopulation of
ileal PP B cells expressed CD40 and it was functional. This
was evident in the binding of soluble mCD40L (Figs 1a and
2) and the induction of a B cell proliferative response that
was specific for mCD40L expressed on transfected J558L
cells (Fig. 1b). Interspecies conservation of CD40 and CD40L
functional domains was apparent when recombinant mouse
and human CD40L displayed equivalent mitogenic activity
with human and mouse B cells (26) and now in the mitogenic
activity of mCD40L with sheep B cells (Fig. 1). Furthermore,
a conservation of the role of CD40 in B cell development was
apparent in the marked similarity between many mCD40L-
induced iPfB cell responses and those reported for mouse
and human B cells (reviewed in 3). These similarities included
rescue from cell death (Figs 3 and 4), blocking anti-lg-induced
cell death (Fig. 3), a reduction in cytoplasmic cAMP (Fig. 5),
the induction of functional IL-2R (Fig. 6) and supporting the
development of slgG1+ B cells (Table 2). All these responses
could contribute to either B cell growth or differentiation and
provide indirect evidence that T cell-dependent interactions
may play a role in iPfB cell development. However, experi-
ments must now be designed to directly determine if either
iPfB cell proliferation or differentiation is influenced by T cell-
dependent antigens.
The relatively low level of CD40 expression on a subpopul-
ation of iPfB cells (Fig. 2) contrasts with the report that all B
cells express CD40, with a lower level of CD40 on resting B
cells and increased CD40 expression following B cell activa-
tion (1). The analyses of sheep B cells in blood (Fig. 2a)
indicated that these resting B cells actually express a higher
level of CD40 than the much larger, rapidly dividing iPfB cells
(Fig. 2b). The apparent absence of CD40 on some FSC'° iPfB
cells (Fig. 2b) suggested that CD40 expression may be down-
regulated on B cells destined to undergo cell death. This
conclusion is supported by the observations that FSC'° iPfB
cells are destined to die (Fig. 4b) and the CD4CT, FSC'° iPfB
cells disappear during culture (Fig. 2c and d). The apparent
absence of CD40 expression, or CD40L binding, on a subpop-
ulation of FSC'° iPfB cells cannot be explained simply by
smaller cell size since this population has a FSC similar to
blood lymphocytes (Fig. 2). Furthermore, that CD40L rescued
-50% of non-S-phase iPfB cells from cell death is consistent
with the expression of a functional CD40 molecule on a
subpopulation of FSC'° iPfB cells (Table 1). Thus, there may
be a brief period during which resting iPfB cells either interact
with CD40L on T cells or become committed to cell death.
Proliferating iPfB cells (BrdU+) are located primarily in the
outer follicle and non-S-phase (BrdlT) iPfB cells are located
in the central follicle, upper follicle, and dome region [P.
Griebel, unpublished observation; (27)]. CD4+ T cells are
distributed in the same regions as non-S-phase iPfB cells
(15) suggesting it may be primarily resting iPfB cells that
would interact with CD4+ T cells. If this is true, then CD40
signalling may play a primary role in iPfB cell differentiation
rather than iPfB cell proliferation. This conclusion would be
consistent with observations that B cell emigration from the
ileal PP increased markedly in lambs after birth (12), a time
when antigen exposure occurs, and that B cell numbers were
decreased in the blood of young lambs that had been
thymectomized and were deficient in CD4+ T cells (28).
A further suggestion that mCD40L may play a role in iPfB
cell differentiation came from the observation that mCD40L
inhibited anti-lg-induced iPfB cell death (Fig. 3). CD40 signal-
ling can also rescue B lymphoma cell lines from anti-lg-
induced cell death (7,8) but this is the first time that a normal,
immature B cell population has been shown to exhibit such
a response. CD40 signalling can also rescue human germinal
centre B cells from programmed cell death (6) and associated
with this response is a reduced level of cytoplasmic cAMP
(9). This led to the suggestion that the cAMP-dependent
second messenger pathway may influence germinal centre
B cell survival and the mCD40L-induced decrease in iPfB cell
cAMP levels (Fig. 5) may be consistent with this hypothesis.
However, CD40 and slgM co-signalling resulted in an elevated
level of cAMP (Fig. 5) indicating that CD40 signalling does
not simply block slgM signalling. It may be that co-signalling
by these molecules resulted in a different state of iPfB cell
activation or differentiation. The state of B cell differentiation
can determine the level of cAMP induced by CD40L since
mature B cells respond with elevated cAMP levels (9). Thus,
it may be that co-signalling by slgM and CD40 induces the
differentiation of immature B cells.
In a number of culture systems, CD40 signalling was
mitogenic for a variety of B cell populations (reviewed in 3).
The CD40L/J558 cells were also mitogenic for iPfB cells (Fig.
1b) but this proliferation was of limited duration despite re-
stimulation with fresh CD40L/J558 cells every 3-4 days (Fig.
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6b). Other co-signals may be necessary to sustain iPfB cell
proliferation since mCD40L rescued non-S-phase iPfB cells
from cell death but viable cell number remained relatively
constant (Fig. 3). Several cytokines have been identified that,
together with CD40 signalling, support B cell proliferation
(reviewed in 3). In particular, IL-4 has been shown to support
long-term growth of human B cells co-stimulated through
CD40 (29). Human IL-4 has no cross-species activity with
sheep iPfB cells (21) but rhlL-2 was mitogenic following CD40
signalling (Fig.6a). CD40L induction of IL-2R (CD25) and IL-
2-responsiveness have also been reported for human tonsillar
B cells (30,31) but only a subpopulation of iPfB cells expressed
IL-2R following CD40 signalling (Table 2) and the expansion
of this subpopulation required exogenous IL-2 (Fig. 6b). Thus,
the limited proliferative response of iPfB cells to rhlL-2 and
mCD40L co-stimulation may be consistent with previous
observations that indicated IL-2 played a role in iPfB cell
differentiation (14). Other unidentified cytokines or cell-cell
interactions may be more important in regulating the growth
of the functionally unique iPfB cell population (17,21). The B
cell proliferation in ileal PP follicles is well established prior
to birth (27) but it remains to be determined if T cell-B cell
interactions may amplify post-natal iPfB cell proliferation.
CD40 signalling resulted in a number of phenotypic
changes in the iPfB cell population. Expression of the
CACT65A molecule was previously observed following iPfB
cell activation by phorbol ester and calcium ionophore (25),
and increased expression of the BAQ44A molecule was
associated with iPfB cell differentiation (14,15). However, this
is the first time that a receptor-ligand interaction has been
identified that can induce the expression of these two molec-
ules on iPfB cells. Of particular note was mCD40L induction
of CD5 expression on 80% of slgM+ iPfB cells (Table 2). This
has not previously been reported for B cells activated by
CD40L but a similar observation was made for human B cells
co-cultured with anti-CD3 activated T cells (33) and these T
cells are known to express CD40L (2). Furthermore, CD5
expression on both slgG1+ and slgM+ B cells (Table 2) has
also been observed for human B cells (33). Thus, as sug-
gested for human B cells (33-35), it may also be true that
CD5 is an activation marker on sheep B cells and not a
B lineage marker as proposed for mice (reviewed in 36).
Furthermore, the present observations suggest that the
expression of CD5 on sheep B cells may indicate that a
cognate T cell-B cell interaction has occurred. The expression
of the CD5 molecule was not unique to cultured iPfB cells as
CD5+ slgM+ and CD5+ slgG1+ B cells were present in both
freshly isolated ileal and jejunal PP B cells (Table 3). However,
CD5+ B cells are usually not found in the blood of young
sheep (P. Griebel, unpublished observation). This may reflect
the presence of a large number of naive B cells or possibly
a down-regulated CD5 expression as reported for resting,
human B cells (33). Finally, other ways of activating B cells
may also induce CD5 expression since increased numbers
of CD5+ B cells have been observed in the blood of sheep
(37) and cattle (38,39) during diseases that cause B cell
activation and phorbol esters can induce CD5 expression on
human B cells (34) and iPfB cells (P. Griebel, unpublished
observation).
When iPfB cells were co-cultured with CD40L/J558 cells ±
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rhlL-2 there was a large increase in slgG1+ B cells but PCs
were primarily lgM+ and very few slgA+ B cells were observed
(Table 2). Furthermore, few slgG1+ B cells were observed
when naive, fetal iPfB cells were co-cultured with CD40L7
J558L cells ± rhlL-2. Thus, mCD40L, alone or with rhlL-2,
appeared unable to induce Ig isotype switching but did
support the growth of lgG1 isotype-switched B cells. It is
difficult to explain the relatively constant number of slgG1 +
cells in iPfB cell co-cultures. However, extensive B cell
turnover in these cultures was indicated by a high level of
proliferation (Fig. 1) that was associated with a relatively
constant cell number (Fig. 3). It may be that differences in
slgG1+ B cell and slgM+ B cell proliferation and survival
result in an early enrichment of slgG1+ B cells that is not
sustained with longer culture periods. CD40L by itself induced
increased lgG1 production by human tonsilar B cells (40) but
exogenous IL-2 induced both lgG1 and IgA secretion (30,40).
The present observations with fetal and lamb iPfB cells (Table
2) suggest that it is only isotype-switched B cells that respond
to CD40L rather than CD40L actually inducing the isotype
switch. Also, of interest was the absence of slgA isotype-
switched B cells in co-cultures with CD40L/J558 cells and
freshly isolated iPfB cells (Table 3). This would be consistent
with the ileal PP being functionally distinct from other gut-
associated lymphoid tissues such as the jejunal PP (Table 3)
which plays a major role in mucosal immunity. Finally, the
presence of some lgG1+ B cells in the ileal PP follicles (Table
3) may provide evidence that antigen-dependent T cell-B
cell interactions do occur in this microenvironment since lgG1
isotype switching is largely T cell-dependent (4,5).
The present investigation of mCD40L confirmed that a
subpopulation of iPfB cells expressed a functional CD40
molecule. However, the paucity of T cells in ileal PP follicles
(15) suggests that there may be limited opportunity for cognate
T cell-B cell interactions to influence iPfB cell development.
Furthermore, immunohistochemistry indicated that it would
be primarily non-S-phase iPfB cells that interacted with CD4+
T cells. Therefore, through an effect on iPfB survival (Figs 3
and 4) and differentiation (Table 2) cognate T cell-B cell
interactions may play a role in the selection of the relatively
small number of B cells that emigrate (11). This hypothesis
has important implications for the generation of the Ig receptor
repertoire in lambs since ileal PP follicles are the major source
of B cells (11,12). It should now be possible to test this
hypothesis since alterations in the T cell repertoire, by immun-
ization with a hapten-carrier protein, should influence the Ig
repertoire of emigrant iPfB cells following exposure to the
haptenated-carrier protein in the gut lumen. Finally, a limited
number of cognate T cell-B cell interactions in lymphoid
follicles of the ileal PP may influence the general level of B
cell proliferation either through the release of T cell cytokines
(Fig. 6) or possibly a recruitment of non-S-phase B cell into
the proliferating B cell pool (Table 1). However, present
observations support the conclusion that the majority of B
cell proliferation in the ileal PP is antigen-independent (17,19).
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